Can We Talk about CD4+CD28– Lymphocytes as a Risk Factor for Ischemic Stroke?

Publisher： Karger

E-ISSN： 1421-9913|58|1|26-33

ISSN： 0014-3022

Source： European Neurology, Vol.58, Iss.1, 2007-05, pp. : 26-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nitric Oxide and Oral Diseases: Can We Talk About It?

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 8, Iss. 2, 2010-01 ,pp. : 104-112

Bentham Science Publishers

Access to resources Recommend Favorite

Serial Measurement of Surface Expressions of CD63, P-Selectin and CD40 Ligand on Platelets in Atherosclerotic Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 16, Iss. 4, 2003-09 ,pp. : 376-382

Karger

Access to resources Recommend Favorite

REGULATION OF 5-LIPOXYGENASE METABOLISM IN MONONUCLEAR PHAGOCYTES BY CD4 T LYMPHOCYTES

By Coffey Michael J.   Phare Susan M.   Peters-Golden Marc   Huffnagle Gary B.  

Experimental Lung Research, Vol. 25, Iss. 7, 1999-10 ,pp. : 617-629

Informa Healthcare

Access to resources Recommend Favorite

Regulation of TAK / P-TEFb in CD4+ T Lymphocytes and Macrophages

By  

Current HIV Research, Vol. 1, Iss. 4, 2003-10 ,pp. : 395-404

Bentham Science Publishers

Access to resources Recommend Favorite

Homocysteine as a Risk Factor for Ischemic Stroke: An Epidemiological Story in Evolution

By  

Neuroepidemiology, Vol. 17, Iss. 4, 1998-07 ,pp. : 167-173

Karger

Access to resources Recommend Favorite